American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013.
2.
BenarousX, RaffinM, FerrafiatV, ConsoliA, CohenD: Catatonia in children and adolescents: New perspectives. Schizophr Res pii: S0920-9964(17)30430-9; 2017. [E-pub ahead of print]; DOI: 10.1016/j.schres.2017.07.028.
3.
CarrollBT: The universal field hypothesis of catatonia and neuroleptic malignant syndrome. CNS Spectr, 5:26–33, 2000.
4.
CurranMP, PerryCM: Amisulpiride: A review of its use in the management of schizophrenia. Drugs, 61:2123–2150, 2001.
5.
DelBelloMP, FosterKD, StrakowskiSM: Case report: Treatment of catatonia in an adolescent male. J Adolesc Health, 27:69–71, 2000.
6.
IshitobiM, KawataniM, AsanoM, KosakaH, GotoT, HirataniM, WadaY: Quetiapine responsive catatonia in an autistic patient with comorbid bipolar disorder and idiopathic basal ganglia calcification. Brain Dev, 36:823–825, 2014.
7.
RaffinM, Zugaj-BensaouL, BodeauN, MilhietV, LaurentC, CohenD, ConsoliA: Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia. Eur Child Adolesc Psychiatry, 24:441–449, 2015.
8.
RobertoAJ, PinnakaS, MohanA, YoonH, LapidusKA.: Adolescent catatonia successfully treated with Lorazepam and aripiprazole. Case Rep Psychiatry, 2014:309517, 2014.
